Risks of phase I research with healthy participants: A systematic review

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Trials

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1740774515602868PMID 26350571PMCID PMC4783291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials

  2015cited by this paper
• Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies

  2015cited by this paper
• All trials must be registered and the results published

  2013cited by this paper
• The Elephant in the (Board) Room: The Role of Contract Research Organizations in International Clinical Research

  2012cited by this paper
• Access to Information and the Right to Health: The Human Rights Case for Clinical Trials Transparency

  2011cited by this paper
• Making Participation Work: A Grounded Theory Describing Participation in Phase I Drug Trials from the Perspective of the Healthy Subject

  2010cited by this paper
• Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov

  2010cited by this paper
• The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects

  2010cited by this paper
• Rethinking Research Ethics

  2010cited by this paper
• Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs

  2010cited by this paper
• When Experiments Travel: Clinical Trials and the Global Search for Human Subjects Adriana Petryna, Princeton University Press, 2009

  2009cited by this paper
• Inadequate Dissemination of Phase I Trials: A Retrospective Cohort Study

  2009cited by this paper
• Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis

  2009cited by this paper
• The need for improved access to FDA reviews.

  2009cited by this paper
• Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials

  2009cited by this paper
• Progress and deficiencies in the registration of clinical trials.

  2009cited by this paper
• Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation

  2008cited by this paper
• Exploiting a research underclass in phase 1 clinical trials.

  2008cited by this paper
• Balancing Justice and Autonomy in Clinical Research With Healthy Volunteers

  2007cited by this paper
• Issues in the registration of clinical trials.

  2007cited by this paper
• Commercializing clinical trials--risks and benefits of the CRO boom.

  2007cited by this paper
• TeGenero fiasco prompts regulatory rethink

  2006cited by this paper
• Compensation for injured research subjects.

  2006cited by this paper
• Establishing risk of human experimentation with drugs: lessons from TGN1412.

  2006cited by this paper
• PIII‐48

  2006cited by this paper
• After the London tragedy, is it still possible to consider Phase I is safe?

  2006cited by this paper
• Strategies to Minimize Risks and Exploitation in Phase One Trials on Healthy Subjects

  2006cited by this paper
• Adverse events in volunteers participating in phase I clinical trials: a single-center five-year survey in 1,559 subjects.

  2005cited by this paper
• Rethinking Research Ethics

  2005cited by this paper
• Scientific research is a moral duty

  2005cited by this paper
• A Taxpayer-Funded Clinical Trials Registry and Results Database

  2004cited by this paper
• The hexamethonium asthma study and the death of a normal volunteer in research

  2002cited by this paper
• Justice for the Professional Guinea Pig

  2001cited by this paper
• Adverse events in phase-I studies: a report in 1015 healthy volunteers

  1998cited by this paper
• Paying people to participate in research: why not? A response to Wilkinson and Moore.

  1997cited by this paper
• Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field.

  1989cited by this paper
• Medical research on normal volunteers [letter]

  1986cited by this paper
• Medical research on normal volunteers.

  1986cited by this paper

• Intentionally Infecting Humans

  2026cites this paper
• Toxicologic Pathology Forum*: Opinion on New Technologies and Trends Disrupting Drug Discovery and Development: How Can the Next Generation of Toxicologic Pathologists Be Prepared for Evolving Roles?

  2025cites this paper
• “Stories like ours continue”: A phenomenological exploration of the lived experiences of ex-serial clinical trial volunteers in South India

  2025cites this paper
• Do people prefer to take part in a clinical trial from home or come to site? A discrete choice experiment in type 2 diabetes mellitus

  2025cites this paper
• Placebo-resistant gut bacteria: Akkermansia muciniphila spp. and Familial Mediterranean fever disease

  2024cites this paper
• Sentinel Dosing—Time for a Risk‐Based Approach?

  2024cites this paper
• Gut Akkermansia muciniphila, Prevotellaceae, and Enterobacteriaceae spp. as Possible Markers in Women-Related Nutritional and Clinical Trials: Familial Mediterranean Fever Disease

  2024cites this paper
• The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case Studies

  2024cites this paper
• European Medicines Agency seeks stakeholders' views on future transparency measures for clinical trials

  2023cites this paper
• Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds

  2022cites this paper
• Risk-benefit analysis of emergency vaccine use

  2022cites this paper
• Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa

  2022cites this paper
• Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials.

  2022cites this paper
• Risk-benefit analysis of emergency vaccine use

  2022cites this paper
• Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity

  2021cites this paper
• Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes

  2021cites this paper
• Promoting Ethical Payment in Human Infection Challenge Studies

  2021cites this paper
• Nonclinical & Clinical Interface - Extrapolation of Nonclinical Data to Support Phase I Clinical Studies.

  2021cites this paper
• Pharmacokinetic-Pharmacodynamic Analysis’ Role in Design of Phase ⅠClinical Trials of Anticoagulant Agents: A Systematic Review

  2020cites this paper
• Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy

  2020cites this paper
• The impact of the global COVID‐19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis

  2020cites this paper
• Safety of healthy subjects in first-in-human multiple-dose studies: A pooled analysis

  2020cites this paper
• Pharmacology‐Guided Rule‐Based Adaptive Dose Escalation in First‐in‐Human Studies

  2020cites this paper
• Commentary on 'Payment in challenge studies: ethics, attitudes and a new payment for risk model'

  2020cites this paper
• The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research

  2020cites this paper
• Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials

  2020cites this paper
• Ethical Issues

  2020cites this paper
• Post an Unforeseen Outcome of Serial Volunteering in Clinical Trials, What Does the Affected Community Want?

  2020cites this paper
• Ethical Issues

  2020cites this paper
• Advancing Ethics and Policy for Healthy‐Volunteer Research through a Model‐Organism Framework

  2019cites this paper
• Novel Targets For Therapeutic Intervention in Inflammatory Bowel Disease. What is the Best Way to Assess the Safety Profile of a Drug?

  2019cites this paper
• “Paid to Endure”: Paid Research Participation, Passivity, and the Goods of Work

  2019cites this paper
• Appraising Harm in Phase I Trials: Healthy Volunteers' Accounts of Adverse Events

  2019cites this paper
• Picking and Choosing Among Phase I Trials

  2019cites this paper
• To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials

  2018cites this paper
• UvA-DARE (Digital Academic Repository) Healthy volunteers’ perceptions of risk in US Phase I clinical trials: A mixed-methods study

  2018cites this paper
• Reviewing the role of healthy volunteer studies in drug development

  2018cites this paper
• Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study

  2018cites this paper
• An Industry Perspective on the 2017 EMA Guideline on First‐in‐Human and Early Clinical Trials

  2018cites this paper
• Healthy Volunteers’ Perceptions of the Benefits of Their Participation in Phase I Clinical Trials

  2018cites this paper
• Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials

  2018cites this paper
• ETHICAL CONSIDERATIONS FOR ZIKA VIRUS HUMAN CHALLENGE TRIALS

  2017cites this paper
• The Bial 10‐2474 Phase 1 Study—A Drug Development Perspective and Recommendations for Future First‐in‐Human Trials

  2017cites this paper
• Current nonclinical testing paradigms in support of safe clinical trials: An IQ Consortium DruSafe perspective

  2017cites this paper
• Consider drug efficacy before first-in-human trials

  2017cites this paper
• 2 A UTHORS

  2017cites this paper
• Is Australia Well Equipped to Deal with Future Clinical Trials?

  2016cites this paper
• Desarrollo clínico de nuevos medicamentos. Seguridad de los ensayos clínicos en voluntarios sanos

  2016cites this paper
• From Altruists to Workers: What Claims Should Healthy Participants in Phase I Trials Have Against Trial Employers?

  2016cites this paper
• Clinical development of new drugs. Safety of clinical trials in healthy volunteers

  2016cites this paper
• [Clinical development of new drugs. Safety of clinical trials in healthy volunteers].

  2016cites this paper